theophylline has been researched along with mesalamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kleinebudde, P; Thommes, M | 1 |
| Calafat, AM; Hauser, R; Hernández-Díaz, S; Kelley, KE; Mitchell, AA | 1 |
| Zhang, F | 1 |
| Ahmed, W; Alhnan, MA; Arafat, B; Isreb, A; Kelarakis, A; Sadia, M; Sośnicka, A | 1 |
1 review(s) available for theophylline and mesalamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for theophylline and mesalamine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
Topics: Acetaminophen; Carrageenan; Cellulose; Chemistry, Pharmaceutical; Drug Implants; Excipients; Mesalamine; Particle Size; Solubility; Surface Properties; Technology, Pharmaceutical; Tensile Strength; Theophylline; Water | 2006 |
Medications as a potential source of exposure to phthalates in the U.S. population.
Topics: Adolescent; Adult; Data Collection; Didanosine; Environmental Exposure; Female; Humans; Male; Mesalamine; Middle Aged; Omeprazole; Pharmaceutical Preparations; Phthalic Acids; Pregnancy; Theophylline; Young Adult | 2009 |
Melt-Extruded Eudragit® FS-Based Granules for Colonic Drug Delivery.
Topics: Chemistry, Pharmaceutical; Colon; Diclofenac; Drug Delivery Systems; Hydrogen-Ion Concentration; Mesalamine; Particle Size; Polymers; Polymethacrylic Acids; Solubility; Technology, Pharmaceutical; Theophylline | 2016 |
Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets.
Topics: Calcium Phosphates; Captopril; Cellulose; Drug Compounding; Drug Liberation; Excipients; Humans; Lactose; Mesalamine; Polymethacrylic Acids; Prednisolone; Printing, Three-Dimensional; Tablets; Talc; Theophylline | 2016 |